Efflux Transporter Avoidance

Efflux Transporter Avoidance is a pharmacokinetic optimization strategy within permeability enhancement that specifically involves the structural modification of drug molecules to minimize recognition and expulsion by efflux transport proteins, thereby improving intracellular or tissue bioavailability.

1

Publications

48

Citations

22

Authors

5

Institutions

Publications per year

2017–2026

1

Authors

22

  1. GM
    Giuliano Malloci

    University of Cagliari, Italy

    1 publications · 48 citations

    1

    h-index

  2. OL
    Olga Lomovskaya

    Mapp Biopharmaceutical (United States), United States

    1 publications · 48 citations

    1

    h-index

  3. EM
    Enrico Margiotta

    University of Padua, Italy

    1 publications · 48 citations

    1

    h-index

  4. RA
    Rachael A. Mansbach

    Los Alamos National Laboratory, United States

    1 publications · 48 citations

    1

    h-index

  5. VV
    Valentin V. Rybenkov

    University of Oklahoma, United States

    1 publications · 48 citations

    1

    h-index

1–5 of 22

Venues

  1. mBio

    1 publications · 48 citations

    1

    h-index

1–1